345 PARK AVENUE SOUTH, NEW YORK, NY
Market cap: $525.5M (2/08/2026)
Price: $7.20
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Jose Manuel Otero Appointed Chief Operating Officer at Lexeo Therapeutics
Investor Presentation
Reports Third Quarter 2025 Financial Results and Operational Highlights
Announces Pricing of Public Offering and Concurrent Private Placement
Reports Second Quarter 2025 Financial Results and Operational Highlights
Shareholder votes
Q3
Q2
Amended Quarterly Report
Q1
FY 2024
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Free Writing Prospectus